3O26 image
Deposition Date 2010-07-22
Release Date 2010-12-15
Last Version Date 2024-11-20
Entry Detail
PDB ID:
3O26
Keywords:
Title:
The structure of salutaridine reductase from Papaver somniferum.
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.91 Å
R-Value Free:
0.20
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 64 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Salutaridine reductase
Gene (Uniprot):SALR
Chain IDs:A
Chain Length:311
Number of Molecules:1
Biological Source:Papaver somniferum
Ligand Molecules
Primary Citation
The atomic structure of salutaridine reductase from the opium poppy Papaver somniferum.
J.Biol.Chem. 66 163 166 (2010)
PMID: 21169353 DOI: 10.1074/jbc.M110.168633

Abstact

The opium poppy (Papaver somniferum L.) is one of the oldest known medicinal plants. In the biosynthetic pathway for morphine and codeine, salutaridine is reduced to salutaridinol by salutaridine reductase (SalR; EC 1.1.1.248) using NADPH as coenzyme. Here, we report the atomic structure of SalR to a resolution of ∼1.9 Å in the presence of NADPH. The core structure is highly homologous to other members of the short chain dehydrogenase/reductase family. The major difference is that the nicotinamide moiety and the substrate-binding pocket are covered by a loop (residues 265-279), on top of which lies a large "flap"-like domain (residues 105-140). This configuration appears to be a combination of the two common structural themes found in other members of the short chain dehydrogenase/reductase family. Previous modeling studies suggested that substrate inhibition is due to mutually exclusive productive and nonproductive modes of substrate binding in the active site. This model was tested via site-directed mutagenesis, and a number of these mutations abrogated substrate inhibition. However, the atomic structure of SalR shows that these mutated residues are instead distributed over a wide area of the enzyme, and many are not in the active site. To explain how residues distal to the active site might affect catalysis, a model is presented whereby SalR may undergo significant conformational changes during catalytic turnover.

Legend

Protein

Chemical

Disease

Primary Citation of related structures